Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan.
Kaori HisanagaHiroshi UchinoNaoko KakisuMasahiko MiyagiFukumi YoshikawaGenki SatoKazutoshi IsobeKazuma KishiSakae HommaTakahisa HirosePublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2021)
Pre-existing diabetes was associated with higher mortality in advanced lung cancer, regardless of irAE development during treatment with ICI.